Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.94 |
| ▸ | CA9 | Q16790 | 1/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.40 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.40 |
| ▸ | FKBP4 | Q02790 | 3/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.32 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL189541 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL1414021 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL1241914 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL7055908 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL16097916 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL6346930 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL918482 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL11552580 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL18695005 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA | |
| SCHEMBL9234110 | 1.00 | CA1 (0.94) | CA1CA9ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| CN-107179661-B | Metal toner composition | 施乐公司 | 2020-04-17 | — | — | CN | disclosed |
| US-6639089-B2 | Therapy, side effect reduction | SODA AROMATIC CO., LTD. | 2003-10-28 | — | — | US | disclosed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | disclosed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | disclosed |
| EP-0143829-B1 | BONDING COMPOSITIONS FOR POLYESTER-POLY(VINYL ALCOHOL) LAMINATES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1987-09-02 | — | — | EP | disclosed |
| US-4576997-A | Adhesive blends | EASTMAN KODAK COMPANY (US) | 1986-03-18 | — | — | US | disclosed |
| EP-0143829-A1 | BONDING COMPOSITIONS FOR POLYESTER-POLY(VINYL ALCOHOL) LAMINATES. | EASTMAN KODAK CO (US) | 1985-06-12 | — | — | EP | disclosed |
| US-4487919-A | Polyester waxes based on 1,12-dodecanedioic acid | EASTMAN KODAK COMPANY (US) | 1984-12-11 | — | — | US | disclosed |
| WO-1984004490-A1 | BONDING COMPOSITIONS FOR POLYESTER-POLY(VINYL ALCOHOL) LAMINATES | EASTMAN KODAK CO (US) | 1984-11-22 | — | — | WO | disclosed |
| US-4482588-A | Bonding compositions and shaped articles utilizing the bonding compositions | EASTMAN KODAK COMPANY (US) | 1984-11-13 | — | — | US | disclosed |
| US-4481238-A | FILMS, BOTTLES, POLYAMIDEESTER COPOLYMER | EASTMAN KODAK COMPANY (US) | 1984-11-06 | — | — | US | disclosed |
| US-4157330-A | Process for the production of cyclic diesters of dodecanedioic acid | CHEMISCHE WERKE HUELS AKTIENGESELLSCHAFT (DE) | 1979-06-05 | — | — | US | disclosed |
| US-4105672-A | THERMOLYSIS, ORGANO-TIN CATALYST | CHEMISCHE WERKE HUELS AKTIENGESELLSCHAFT (DE) | 1978-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | CA1 1636/4885CA9 1111/4885ALDH1A1 397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.